Our Mission

Create a tomorrow where

infectious diseases that, today, last a lifetime
can be cured.

Our Science

ImmuNovX Biotech is an early-stage company focused on developing our proprietary platform technology, Antig3NX®, which powers rapid,

large-scale production of antigens for use in novel immunotherapeutics to combat infectious diseases with the highest unmet need.

Partnering

ImmuNovX is actively seeking partners and collaborators, and would value the opportunity to discuss potential synergies.

ImmuNovX® Biotech
116 Research Drive, Suite 2226
Bethlehem, PA 18015
610-941-4750